JP2019514970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514970A5 JP2019514970A5 JP2018558199A JP2018558199A JP2019514970A5 JP 2019514970 A5 JP2019514970 A5 JP 2019514970A5 JP 2018558199 A JP2018558199 A JP 2018558199A JP 2018558199 A JP2018558199 A JP 2018558199A JP 2019514970 A5 JP2019514970 A5 JP 2019514970A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antimetabolite
- individual
- bladder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021172052A JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662333151P | 2016-05-06 | 2016-05-06 | |
| US62/333,151 | 2016-05-06 | ||
| US201762443614P | 2017-01-06 | 2017-01-06 | |
| US62/443,614 | 2017-01-06 | ||
| PCT/US2017/031445 WO2017193098A1 (en) | 2016-05-06 | 2017-05-05 | Method of treating lower tract urothelial cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172052A Division JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514970A JP2019514970A (ja) | 2019-06-06 |
| JP2019514970A5 true JP2019514970A5 (enExample) | 2020-06-18 |
| JP7712055B2 JP7712055B2 (ja) | 2025-07-23 |
Family
ID=60203435
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558199A Active JP7712055B2 (ja) | 2016-05-06 | 2017-05-05 | 下部尿路上皮がんを処置する方法 |
| JP2021172052A Withdrawn JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A Withdrawn JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172052A Withdrawn JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A Withdrawn JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20190388338A1 (enExample) |
| EP (2) | EP3452053B1 (enExample) |
| JP (3) | JP7712055B2 (enExample) |
| KR (2) | KR20220123317A (enExample) |
| CN (2) | CN118453872A (enExample) |
| AU (1) | AU2017261371B2 (enExample) |
| CA (1) | CA3023274A1 (enExample) |
| ES (1) | ES2940227T3 (enExample) |
| FI (1) | FI3452053T3 (enExample) |
| HR (1) | HRP20221544T1 (enExample) |
| HU (1) | HUE060965T2 (enExample) |
| IL (2) | IL295592A (enExample) |
| LT (1) | LT3452053T (enExample) |
| MX (2) | MX389296B (enExample) |
| NZ (3) | NZ748252A (enExample) |
| PL (1) | PL3452053T3 (enExample) |
| PT (1) | PT3452053T (enExample) |
| RS (1) | RS64032B1 (enExample) |
| RU (2) | RU2022100624A (enExample) |
| SG (2) | SG11201809838VA (enExample) |
| SI (1) | SI3452053T1 (enExample) |
| SM (1) | SMT202300047T1 (enExample) |
| WO (1) | WO2017193098A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3370768T3 (da) | 2015-11-03 | 2022-03-21 | Janssen Biotech Inc | Antistoffer som specifikt binder pd-1 og anvendelser deraf |
| MX2019003683A (es) | 2016-10-11 | 2019-08-22 | Agenus Inc | Anticuerpos anti gen 3 de activación linfocítica (lag 3 ) y métodos para usarlos. |
| SG10201913998YA (en) * | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| MX2020004771A (es) | 2017-11-08 | 2020-10-19 | Taris Biomedical Llc | Metodos de tratamiento y terapia de mantenimiento para el cancer de vejiga con gemcitabina. |
| US12398209B2 (en) | 2018-01-22 | 2025-08-26 | Janssen Biotech, Inc. | Methods of treating cancers with antagonistic anti-PD-1 antibodies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30915A1 (es) * | 2007-02-16 | 2008-09-02 | Smithkline Beecham Corp | Método de tratamiento de canceres |
| EA023156B1 (ru) | 2009-06-26 | 2016-04-29 | ТАРИС Биомедикал ЛЛК | Устройство для доставки лекарств |
| DK2512581T3 (da) | 2009-12-17 | 2021-03-29 | Taris Biomedical Llc | Implanterbar indretning med intravesikal tolerance |
| MX343671B (es) * | 2010-06-02 | 2016-11-16 | Abraxis Bioscience Llc * | Metodos de tratamiento de cancer de vejiga. |
| EP2600800B1 (en) | 2010-08-05 | 2020-09-30 | TARIS Biomedical LLC | Ureteral stent drug delivery device and kit |
| BR112013019410A2 (pt) | 2011-02-04 | 2019-09-24 | Taris Biomedical Inc | dispositivo implantável para liberação controlada de fármaco de solubilidade baixa |
| CN104470535A (zh) * | 2012-03-29 | 2015-03-25 | 阿尔托生物科学有限公司 | 用于治疗肿瘤的方法 |
| PL2890384T3 (pl) * | 2012-08-31 | 2022-02-14 | Taris Biomedical Llc | Układy podawania leku i sposoby leczenia raka pęcherza obejmujące oksaliplatynę |
| CA2882575C (en) | 2012-08-31 | 2020-05-26 | Dennis GIESING | Drug delivery systems and methods for treatment of prostate |
| EP2964310A1 (en) | 2013-03-05 | 2016-01-13 | TARIS Biomedical LLC | Drug delivery devices and methods for controlled drug release through device orifice |
| AU2014227914B2 (en) | 2013-03-15 | 2018-05-10 | Taris Biomedical Llc | Drug delivery devices and methods for drug delivery |
| PT2968880T (pt) | 2013-03-15 | 2025-07-07 | Taris Biomedical Llc | Dispositivos de aplicação de fármaco com componente permeável a fármaco |
| KR102503010B1 (ko) | 2013-08-19 | 2023-02-24 | 타리스 바이오메디컬 엘엘씨 | 다중 유닛 약물 전달 장치 및 방법 |
| CN119950539A (zh) | 2014-03-06 | 2025-05-09 | 塔里斯生物医药公司 | 用吉西他滨来治疗膀胱癌的药物递送系统和方法 |
| AU2015279674B2 (en) | 2014-06-26 | 2020-07-23 | Taris Biomedical Llc | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
-
2017
- 2017-05-05 NZ NZ748252A patent/NZ748252A/en unknown
- 2017-05-05 SI SI201731301T patent/SI3452053T1/sl unknown
- 2017-05-05 SM SM20230047T patent/SMT202300047T1/it unknown
- 2017-05-05 EP EP17793523.6A patent/EP3452053B1/en active Active
- 2017-05-05 HU HUE17793523A patent/HUE060965T2/hu unknown
- 2017-05-05 RS RS20230163A patent/RS64032B1/sr unknown
- 2017-05-05 WO PCT/US2017/031445 patent/WO2017193098A1/en not_active Ceased
- 2017-05-05 EP EP22212024.8A patent/EP4209221A1/en active Pending
- 2017-05-05 IL IL295592A patent/IL295592A/en unknown
- 2017-05-05 CN CN202410626384.1A patent/CN118453872A/zh active Pending
- 2017-05-05 SG SG11201809838VA patent/SG11201809838VA/en unknown
- 2017-05-05 HR HRP20221544TT patent/HRP20221544T1/hr unknown
- 2017-05-05 MX MX2018013432A patent/MX389296B/es unknown
- 2017-05-05 NZ NZ787786A patent/NZ787786A/en unknown
- 2017-05-05 RU RU2022100624A patent/RU2022100624A/ru unknown
- 2017-05-05 CA CA3023274A patent/CA3023274A1/en active Pending
- 2017-05-05 JP JP2018558199A patent/JP7712055B2/ja active Active
- 2017-05-05 CN CN201780040391.1A patent/CN109475571A/zh active Pending
- 2017-05-05 NZ NZ787824A patent/NZ787824A/en unknown
- 2017-05-05 RU RU2018142908A patent/RU2764747C2/ru active
- 2017-05-05 AU AU2017261371A patent/AU2017261371B2/en active Active
- 2017-05-05 FI FIEP17793523.6T patent/FI3452053T3/fi active
- 2017-05-05 KR KR1020227028547A patent/KR20220123317A/ko not_active Ceased
- 2017-05-05 KR KR1020187035297A patent/KR102435709B1/ko active Active
- 2017-05-05 LT LTEPPCT/US2017/031445T patent/LT3452053T/lt unknown
- 2017-05-05 PT PT177935236T patent/PT3452053T/pt unknown
- 2017-05-05 IL IL262746A patent/IL262746B/en unknown
- 2017-05-05 SG SG10201913416PA patent/SG10201913416PA/en unknown
- 2017-05-05 ES ES17793523T patent/ES2940227T3/es active Active
- 2017-05-05 US US16/099,179 patent/US20190388338A1/en active Pending
- 2017-05-05 PL PL17793523.6T patent/PL3452053T3/pl unknown
-
2018
- 2018-11-01 MX MX2021013461A patent/MX2021013461A/es unknown
-
2021
- 2021-10-21 JP JP2021172052A patent/JP2022009327A/ja not_active Withdrawn
-
2023
- 2023-12-07 JP JP2023206570A patent/JP2024028881A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Immune checkpoint inhibitors in 10 years: contribution of basic research and clinical application in cancer immunotherapy | |
| JP2019514970A5 (enExample) | ||
| US10076528B2 (en) | System and method for diagnosis and treatment | |
| Antonia et al. | Immuno-oncology combinations: a review of clinical experience and future prospects | |
| JP2019522657A5 (enExample) | ||
| Goessl et al. | The development of denosumab for the treatment of diseases of bone loss and cancer‐induced bone destruction | |
| RU2022100624A (ru) | Способ лечения рака уротелия нижних путей | |
| BR112020008537A2 (pt) | inibidores duplos de vias da tim-3 e da pd-1 | |
| Shaikh et al. | Engineering stent based delivery system for esophageal cancer using docetaxel | |
| Denlinger et al. | A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers | |
| Hoag et al. | Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review | |
| Coloma et al. | High incidence of cetuximab-related infusion reactions in head and neck patients | |
| CN101612141B (zh) | 丁丙诺啡贴剂 | |
| CN119923256A (zh) | 包含大麻素的连续递送系统及其医药用途 | |
| Knight et al. | Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine | |
| WO2025235493A1 (en) | Casdatifan for use in the treatment of cancer | |
| Islam et al. | Marital Status and Survival in Patients with Multiple Myeloma: The Role of Marriage in the Management of Multiple Myeloma | |
| JPWO2021062244A5 (enExample) | ||
| Seminario-Vidal et al. | 283 Toxic epidermal necrolysis in the setting of acute graft-versus-host disease successfully treated with tumor necrosis factor alpha inhibitors | |
| Vidal et al. | Legionella in a patient with rheumatoid arthritis receiving abatacept | |
| Yang et al. | Hepatic Arterial Infusion Chemotherapy combined with Tislelizumab and Donafenib induced Toxic Epidermal Necrolysis in a Primary Liver Carcinoma Patient-A case report | |
| HK40005970A (en) | Method of treating lower tract urothelial cancer | |
| BR122024005298A2 (pt) | Usos de antimetabólitos no tratamento de câncer urotelial do trato inferior, kits e dispositivo de liberação | |
| HK40044298A (en) | Microbiome related immunotherapies |